ATE430747T1 - 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren - Google Patents
2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitorenInfo
- Publication number
- ATE430747T1 ATE430747T1 AT05853157T AT05853157T ATE430747T1 AT E430747 T1 ATE430747 T1 AT E430747T1 AT 05853157 T AT05853157 T AT 05853157T AT 05853157 T AT05853157 T AT 05853157T AT E430747 T1 ATE430747 T1 AT E430747T1
- Authority
- AT
- Austria
- Prior art keywords
- pyrimidinyl
- pyrazolopyridine
- kinase inhibitors
- erbb kinase
- erbb
- Prior art date
Links
- HBCVWXFOEDDNNR-UHFFFAOYSA-N 2-pyrimidin-2-ylpyrazolo[4,3-b]pyridine Chemical compound N1=C2C=CC=NC2=CN1C1=NC=CC=N1 HBCVWXFOEDDNNR-UHFFFAOYSA-N 0.000 title abstract 2
- 102000001301 EGF receptor Human genes 0.000 title 1
- 101000851181 Homo sapiens Epidermal growth factor receptor Proteins 0.000 title 1
- 229940043355 kinase inhibitor Drugs 0.000 title 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008177 pharmaceutical agent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63792804P | 2004-12-21 | 2004-12-21 | |
| US70907905P | 2005-08-17 | 2005-08-17 | |
| PCT/US2005/044166 WO2006068826A2 (en) | 2004-12-21 | 2005-12-06 | 2-pyrimidinyl pyrazolopyridine erbb kinase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE430747T1 true ATE430747T1 (de) | 2009-05-15 |
Family
ID=36588699
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05853157T ATE430747T1 (de) | 2004-12-21 | 2005-12-06 | 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1828185B1 (de) |
| JP (1) | JP5132319B2 (de) |
| AT (1) | ATE430747T1 (de) |
| DE (1) | DE602005014382D1 (de) |
| ES (1) | ES2325035T3 (de) |
| WO (1) | WO2006068826A2 (de) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7812022B2 (en) | 2004-12-21 | 2010-10-12 | Glaxosmithkline Llc | 2-pyrimidinyl pyrazolopyridine ErbB kinase inhibitors |
| JP5186219B2 (ja) * | 2005-01-25 | 2013-04-17 | エピックス デラウェア， インコーポレイテッド | 置換アリールアミン化合物および５−ｈｔ６調節因子としてのその使用 |
| WO2007067506A2 (en) * | 2005-12-05 | 2007-06-14 | Smithkline Beecham Corporation | 2-pyrimidinyl pyrazolopyridine erbb kinase inhibitors |
| WO2008003766A2 (en) * | 2006-07-06 | 2008-01-10 | Boehringer Ingelheim International Gmbh | 4-heter0cycl0alkylpyri(mi)dines, process for the preparation thereof and their use as medicaments |
| ES2539518T3 (es) * | 2007-04-24 | 2015-07-01 | Astrazeneca Ab | Inhibidores de proteínas quinasas |
| US8067409B2 (en) | 2007-11-27 | 2011-11-29 | Abbott Laboratories | Protein kinase inhibitors |
| HRP20170317T1 (hr) | 2008-02-15 | 2017-04-21 | Rigel Pharmaceuticals, Inc. | Spojevi pirimidin-2-amina i njihova uporaba kao inhibitora jak kinaza |
| UA103319C2 (en) | 2008-05-06 | 2013-10-10 | Глаксосмитклайн Ллк | Thiazole- and oxazole-benzene sulfonamide compounds |
| US9273077B2 (en) | 2008-05-21 | 2016-03-01 | Ariad Pharmaceuticals, Inc. | Phosphorus derivatives as kinase inhibitors |
| JP2011523646A (ja) | 2008-05-21 | 2011-08-18 | アリアド・ファーマシューティカルズ・インコーポレイテッド | キナーゼ阻害剤としてのリン誘導体 |
| ES2422263T3 (es) * | 2008-12-19 | 2013-09-10 | Nerviano Medical Sciences Srl | Pirazoles bicíclicos como inhibidores de la proteinquinasa |
| EP2435435B1 (de) * | 2009-05-27 | 2014-01-29 | AbbVie Inc. | Pyrimidinhemmer der kinaseaktivität |
| CN102459264A (zh) * | 2009-05-27 | 2012-05-16 | 雅培制药有限公司 | 激酶活性的嘧啶抑制剂 |
| CA2778265A1 (en) * | 2009-11-02 | 2011-05-05 | Abbott Laboratories | Imidazopyridines as a novel scaffold for multi-targeted kinase inhibition |
| EP2360158A1 (de) * | 2010-02-18 | 2011-08-24 | Almirall, S.A. | Pyrazolderivate als JAK-Inhibitoren |
| UY33213A (es) * | 2010-02-18 | 2011-09-30 | Almirall Sa | Derivados de pirazol como inhibidores de jak |
| AR080375A1 (es) | 2010-03-05 | 2012-04-04 | Sanofi Aventis | Procedimiento para la preparacion de 2-(cicloheximetil)-n-{2-[(2s)-1-metilpirrolidin-2-il] etil}-1,2,3,4-tetrahidroisoquinolina- 7-sulfonamida |
| EP2402336A1 (de) * | 2010-06-29 | 2012-01-04 | Basf Se | Pyrazolopyridin-Verbindungen |
| EP2463289A1 (de) | 2010-11-26 | 2012-06-13 | Almirall, S.A. | Imidazo[1,2-b]Pyridazin-Derivate als AS JAK-Hemmer |
| AU2012250517B2 (en) | 2011-05-04 | 2016-05-19 | Takeda Pharmaceutical Company Limited | Compounds for inhibiting cell proliferation in EGFR-driven cancers |
| DK3686193T3 (da) * | 2011-07-27 | 2022-05-30 | Astrazeneca Ab | 2-(2,4,5-substitueret anilino)pyrimidinforbindelser |
| EP2554544A1 (de) | 2011-08-01 | 2013-02-06 | Almirall, S.A. | Pyridin-2(1H-)-on-Derivate als JAK-Inhibitoren |
| JP6469567B2 (ja) | 2012-05-05 | 2019-02-13 | アリアド・ファーマシューティカルズ・インコーポレイテッド | Ｅｇｆｒ発動性がんの細胞増殖阻害用化合物 |
| LT2925757T (lt) * | 2012-11-19 | 2017-12-27 | Novartis Ag | Junginiai ir kompozicijos, skirti parazitinių ligų gydymui |
| US9611283B1 (en) | 2013-04-10 | 2017-04-04 | Ariad Pharmaceuticals, Inc. | Methods for inhibiting cell proliferation in ALK-driven cancers |
| CN104829613B (zh) * | 2015-04-13 | 2020-06-09 | 赤峰蒙广生物科技有限公司 | 二芳基取代的吡唑并环类衍生物、其制备方法及其在医药领域的应用 |
| US11066404B2 (en) | 2018-10-11 | 2021-07-20 | Incyte Corporation | Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors |
| WO2020168197A1 (en) | 2019-02-15 | 2020-08-20 | Incyte Corporation | Pyrrolo[2,3-d]pyrimidinone compounds as cdk2 inhibitors |
| TW202100520A (zh) | 2019-03-05 | 2021-01-01 | 美商英塞特公司 | 作為cdk2 抑制劑之吡唑基嘧啶基胺化合物 |
| JP2022526159A (ja) | 2019-03-29 | 2022-05-23 | アストラゼネカ・アクチエボラーグ | 非小細胞肺がんの治療に使用するためのオシメルチニブ |
| US11919904B2 (en) | 2019-03-29 | 2024-03-05 | Incyte Corporation | Sulfonylamide compounds as CDK2 inhibitors |
| WO2020223558A1 (en) | 2019-05-01 | 2020-11-05 | Incyte Corporation | Tricyclic amine compounds as cdk2 inhibitors |
| WO2020223469A1 (en) | 2019-05-01 | 2020-11-05 | Incyte Corporation | N-(1-(methylsulfonyl)piperidin-4-yl)-4,5-di hydro-1h-imidazo[4,5-h]quinazolin-8-amine derivatives and related compounds as cyclin-dependent kinase 2 (cdk2) inhibitors for treating cancer |
| WO2021030537A1 (en) | 2019-08-14 | 2021-02-18 | Incyte Corporation | Imidazolyl pyrimidinylamine compounds as cdk2 inhibitors |
| CR20220170A (es) | 2019-10-11 | 2022-10-10 | Incyte Corp | Aminas bicíclicas como inhibidoras de la cdk2 |
| US11981671B2 (en) | 2021-06-21 | 2024-05-14 | Incyte Corporation | Bicyclic pyrazolyl amines as CDK2 inhibitors |
| US11976073B2 (en) | 2021-12-10 | 2024-05-07 | Incyte Corporation | Bicyclic amines as CDK2 inhibitors |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS49779B (sr) * | 1998-01-12 | 2008-06-05 | Glaxo Group Limited, | Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze |
| PE20020506A1 (es) * | 2000-08-22 | 2002-07-09 | Glaxo Group Ltd | Derivados de pirazol fusionados como inhibidores de la proteina cinasa |
-
2005
- 2005-12-06 WO PCT/US2005/044166 patent/WO2006068826A2/en not_active Ceased
- 2005-12-06 EP EP05853157A patent/EP1828185B1/de not_active Expired - Lifetime
- 2005-12-06 AT AT05853157T patent/ATE430747T1/de not_active IP Right Cessation
- 2005-12-06 JP JP2007546747A patent/JP5132319B2/ja not_active Expired - Fee Related
- 2005-12-06 DE DE602005014382T patent/DE602005014382D1/de not_active Expired - Lifetime
- 2005-12-06 ES ES05853157T patent/ES2325035T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006068826A3 (en) | 2006-10-05 |
| EP1828185B1 (de) | 2009-05-06 |
| DE602005014382D1 (de) | 2009-06-18 |
| WO2006068826A2 (en) | 2006-06-29 |
| JP2008524220A (ja) | 2008-07-10 |
| JP5132319B2 (ja) | 2013-01-30 |
| EP1828185A2 (de) | 2007-09-05 |
| ES2325035T3 (es) | 2009-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602005014382D1 (de) | 2-pyrimidinyl-pyrazolopyridin-erbb-kinaseinhibitoren | |
| WO2007067506A3 (en) | 2-pyrimidinyl pyrazolopyridine erbb kinase inhibitors | |
| CY1109916T1 (el) | Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις | |
| TW200610531A (en) | Phthalazine derivatives as PARP inhibitors | |
| MY169515A (en) | Quinazolinedione derivatives as parp inhibitors | |
| SE0301372D0 (sv) | Novel compounds | |
| SG154434A1 (en) | Quinazolinone derivatives as parp inhibitors | |
| SE0301700D0 (sv) | Novel compounds | |
| SE0101675D0 (sv) | Novel composition | |
| ATE479687T1 (de) | Kinaseinhibitoren | |
| EA200971051A1 (ru) | Ингибиторы p70 s6 киназы | |
| NO20071915L (no) | Diaminotriazolforbindelser nyttige som proteinkinaseinhibitorer | |
| AU2003228770A8 (en) | Substituted pyrazolopyrimidines | |
| EA200970156A1 (ru) | Пиридизиноновые производные | |
| UA86591C2 (ru) | Пирролодигидроизохинолины как ингибиторы pde10, фармацевтическая композиция на их основе | |
| TW200624426A (en) | BACE inhibitors | |
| TW200736227A (en) | New compounds III | |
| UA85505C2 (en) | Kinase inhibitors | |
| WO2007056625A3 (en) | Thienopyridine b-raf kinase inhibitors | |
| WO2007120333A3 (en) | Tetracyclic kinase inhibitors | |
| ATE274515T1 (de) | Pyrazolopyridinderivate | |
| ATE507218T1 (de) | Benzodiazepin-derivate als rock-kinasen hemmer | |
| ATE548364T1 (de) | Aminopyrazolkinasehemmer | |
| BRPI0615141A2 (pt) | inibidores pentacìclicos de quinase | |
| UA92180C2 (en) | Benzimidazole thiophene compounds as plk inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |